This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
AI is now as much a part of U.S. healthcare as any other technology category in wide use across the sector. However, like no other technology, its role is “being actively shaped, not passively adopted” by clinicians and patients alike.
A recent OIG report suggested vascular surgeons, interventional cardiologists and interventional radiologists may be performing medically unnecessary procedures in office-based labs. Now, some of the leading medical societies from those fields have provided additional context.
Asking medical questions of AI with language spoken “in the wild”—meaning with LLM prompts from everyday consumers—brings back answers with decidedly mediocre accuracy, a new study shows.
A system-wide initiative in Sweden helped hospitals reduce readmission rates and shorten lengths of stay. When it came to heart failure patients specifically, however, the changes barely made an impact.
As one may expect, patient satisfaction was considerably higher for individuals who did not have to fast for a minimum of six hours prior to treatment. There were no other significant differences.
Not long ago, physicians and grocery clerks had a key duty in common: ‘connective labor.’ Today barcode reading machines sweep you through the checkout. And AI can handle most of your health questions.
Clinicians who come to rely on AI for decision support risk the dulling of their skills.The concern is not new. But now comes a pointed call to researchers: Inquire about the particulars of the peril.
With patients gaining access to imaging reports earlier than ever, it's critical they have access to large language models that can accurately summarize the results.
New data on the RDN systems from Recor Medical and Medtronic confirmed that this relatively new technology brings long-term relief to patients with uncontrolled hypertension.
Shockwave Medical and FastWave Medical have shared new first-in-human data on their advanced IVL offerings. Both companies are focused on addressing difficult-to-cross lesions that often cause problems for cardiologists.